CORONARY ARTERY PERFORATION side effect
What is CORONARY ARTERY PERFORATION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
CORONARY ARTERY PERFORATION and Recently Reported Side Effects
CORONARY ARTERY PERFORATION and 15 most Active Side Effect polls
CORONARY ARTERY PERFORATION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Angiomax Side Effects Report #5624763-2
Health Professional from UNITED STATES reported ANGIOMAX problem on Jan 29, 2008. Female patient was diagnosed with percutaneous coronary intervention and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: coronary artery perforation, . ANGIOMAX dosage: 0.75 MG/KG, BOLUS; IV BOLUS ; 1.75 MG/KG, HR, INTRAVENOUS. Patient recovered.
Angiomax Side Effects Report #5761920-9
ANGIOMAX problem was reported by a Physician from UNITED STATES on May 19, 2008. Female patient, 65 years of age, was diagnosed with percutaneous coronary intervention and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: coronary artery perforation, . ANGIOMAX dosage: unknown. Patient died.
Angiomax Side Effects Report #5703572-X
Health Professional from UNITED STATES reported ANGIOMAX problem on Mar 27, 2008. Female patient was diagnosed with percutaneous coronary intervention and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: coronary artery perforation, . ANGIOMAX dosage: 0.75 MG/KG, BOLUS, INTRAVENOUS, 1.75 MG/KG, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Angiomax Side Effects Report #5293979-X
ANGIOMAX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2007. Male patient was diagnosed with coronary angioplasty and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: coronary artery perforation, iatrogenic injury, procedural complication, . ANGIOMAX dosage: unknown. During the same period patient was treated with ASPIRIN. Patient recovered.
Lupron Side Effects Report #5313452-X
Health Professional from CANADA reported LUPRON DEPOT problem on Apr 11, 2007. Male patient, 64 years of age, was diagnosed with prostate cancer and was treated with LUPRON DEPOT. After drug was administered, patient experienced the following problems/side effects: coronary artery occlusion, coronary artery perforation, dysuria, pneumonia, post procedural infection, . LUPRON DEPOT dosage: 30 MG, 1 IN 4 M, INTRAMUSCULAR. During the same period patient was treated with CRESTOR, ATENOLOL, ASPIRIN, DIOVAN, NITROGLYCERIN SPRAY, TERAZOSIN. Patient was hospitalized. Patient recovered.
Angiomax Side Effects Report #5624762-0
ANGIOMAX problem was reported by a Physician from UNITED STATES on Jan 29, 2008. Female patient, 79 years of age, was diagnosed with percutaneous coronary intervention and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, cardiac tamponade, coronary artery perforation, vomiting, . ANGIOMAX dosage: 0.75 MG/KG, BOLUS; IV BOLUS; 1.75 MG/KG, HR, INTRAVENOUS. Patient died on 01/25/2008.
Angiomax Side Effects Report #5484470-6
Consumer or non-health professional from UNITED STATES reported ANGIOMAX problem on Sept 27, 2007. Female patient, 54 years of age, weighting 110.2 lb, was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, coagulation time prolonged, coronary artery perforation, international normalised ratio increased, prothrombin time prolonged, . ANGIOMAX dosage: 8.3 ML BOLUS, IV BOLUS; 15.3 ML HR, INTRAVENOUS. During the same period patient was treated with HEPARIN. Patient recovered.
Angiomax Side Effects Report #5731094-9
ANGIOMAX problem was reported by a Health Professional from UNITED STATES on Apr 18, 2008. Female patient, 88 years of age, weighting 145.5 lb, was diagnosed with percutaneous coronary intervention and was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, cardio-respiratory arrest, coronary artery perforation, coronary artery thrombosis, . ANGIOMAX dosage: 0.75 MG/KG, BOLUS, INTRAVENOUS, 1.75 MG/KG, HR, INTRAVENOUS. During the same period patient was treated with ASPIRIN, PLAVIX, LOPRESSOR. Patient died on 04/07/2008.
Nitrolingual Side Effects Report #5299501-6
Consumer or non-health professional from reported NITROLINGUAL PUMPSPRAY problem on Apr 12, 2007. Male patient, 70 years of age, weighting 176.4 lb, was treated with NITROLINGUAL PUMPSPRAY. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, cardiac tamponade, coronary artery perforation, electromechanical dissociation, myocardial rupture, . NITROLINGUAL PUMPSPRAY dosage: unknown. During the same period patient was treated with ASPIRIN, METOPROLOL SUCCINATE, DURIDE, SIMVASTATIN, OMEPRAZOLE, METOCLOPRAMIDE, MORPHINE, CILAZAPRIL. Patient died on 02/23/2007.